Anthem Blue Cross (HMO, PPO, EPO)
Mektovi (binimetinib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: 2 capsules per 1 day(s).
  • Step Therapy: ST_APPLIES
  • Hemophilia A (Factor VIII):
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Dosing Limit(s): N/A
    Diagnosis Type(s): 1 of Mild to moderate;Severe
    Diagnosis Treatments: 1 of Bleeding episodes;Routine propylaxis
    Treatment Center Required: No

    Hemophilia A or B with Inhibitor:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified
    Dosing Limit(s): N/A
    Diagnosis Type(s): 1 of Mild to moderate;Severe
    Diagnosis Treatments: 1 of Bleeding episodes;Routine propylaxis
    Treatment Center Required: No
    Dosing Limits Exist: No

  • Step Therapy: CIDP: Immune Globulin, PID: Immune Globulin:
    ST Single Brand

    Immune Thrombocytopenic Purpura (ITP):
    ST Multiple Brands

    Pemphigus Vulgaris:
    ST Single Generic


  • For FAX form click HERE
    Our electronic prior authorization (ePA) process is the preferred method for submitting pharmacy prior authorization requests. Creating an account is free, easy and helps patients get their medications sooner. You can complete the process through your current electronic health record/electronic medical record (EHR/EMR) system or by using one of these ePA sites:
     Log in to Surescripts
     Log in to CoverMyMeds; For details on morphine equivalent dose criteria click  HERE
    For details on quantity criteria click  HERE
    7 days supply per fill; 14 days supply per 30 days
    For details on drug coverage click  HERE;